Abstract:The use of peptide–drug conjugates is emerging as a powerful strategy for targeted drug delivery. Previously, we have found that peptides conjugated to a non-steroidal anti-inflammatory drug (NSAID), more specifically naproxen–dehydrodipeptide conjugates, readily form nanostructured fibrilar supramolecular hydrogels. These hydrogels were revealed as efficacious nano-carriers for drug delivery applications. Moreover, the incorporation of superparamagnetic iron oxide nanoparticles (SPIONs) rendered the hydrogels responsive to external magnetic fields, undergoing gel-to-solution phase transition upon remote magnetic excitation. Thus, magnetic dehydrodipeptide-based hydrogels may find interesting applications as responsive Magnetic Resonance Imaging (MRI) contrast agents and for magnetic hyperthermia-triggered drug-release applications. Supramolecular hydrogels where the hydrogelator molecule is endowed with intrinsic pharmacological properties can potentially fulfill a dual function in drug delivery systems as (passive) nanocariers for incorporated drugs and as active drugs themselves. In this present study, we investigated the pharmacological activities of a panel of naproxen–dehydrodipeptide conjugates, previously studied for their hydrogelation ability and as nanocarriers for drug-delivery applications. A focused library of dehydrodipeptides, containing N-terminal canonical amino acids (Phe, Tyr, Trp, Ala, Asp, Lys, Met) N-capped with naproxen and linked to a C-terminal dehydroaminoacid (ΔPhe, ΔAbu), were evaluated for their anti-inflammatory and anti-cancer activities, as well as for their cytotoxicity to non-cancer cells, using a variety of enzymatic and cellular assays. All compounds except one were able to significantly inhibit lipoxygenase (LOX) enzyme at a similar level to naproxen. One of the compounds 4 was able to inhibit the cyclooxygenase-2 (COX-2) to a greater extent than naproxen, without inhibiting cyclooxygenase-1 (COX-1), and therefore is a potential lead in the search for selective COX-2 inhibitors. This hydrogelator is a potential candidate for dual COX/LOX inhibition as an optimised strategy for treating inflammatory conditions.

Synthesis, characterization and biological evaluation of naproxen Cu(II) complexes

Synthesis, Characterization, and Biological Evaluation of a Novel Zn(II)-Naproxen Complex

New Cu+2 Complexes with N-Sulfonamide Ligands: Potential Antitumor, Antibacterial, and Antioxidant Agents

Heterogeneous Oxidation of Naproxen in the Presence of Α-Mno2 Nanostructures with Different Morphologies

Novel manganese carbon quantum dots as a nano-probe: Facile synthesis, characterization and their application in naproxen delivery (Mn/CQD/SiO2@naproxen)

Synthesis, Inhibitory Activity and Molecular Docking Studies of Two Cu(II) Complexes Against Helicobacter Pylori Urease.

Transition metal(II) complexes with the non-steroidal anti-inflammatory drug oxaprozin: Characterization and biological profile

Identification of in vitro α-glucosidase and urease inhibitory effect, and in silico studies of Naproxen-derived 1,3,4-oxadiazole-based Schiff-base derivatives

Synthesis, Structural, DFT, In Vitro Biological Exploration, and DNA Interaction of New Ni(II) and Cu(II) Mixed‐Ligand Complexes Featuring 2,2′‐Pyridine‐2,6‐diylbis(1H‐benzimidazole) and 2‐Hydroxy‐naphthaldehyde‐Based Schiff‐Base

Syntheses, Crystal Structures and Antitumor Activity of Ni((II)/Zn(II) Complexes Containing Cephalexin Hydrolysate

Exploring the potential of propanamide-sulfonamide based drug conjugates as dual inhibitors of urease and cyclooxygenase-2: biological and their in silico studies

Synthesis, characterization and antiproliferative activity of transition metal complexes with 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid (oxaprozin)

Synthesis, Molecular Docking, and Inhibitory Activity of a Ni Schiff-base Complex Against Urease

Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition

Biological Evaluation of Naproxen–Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors

Coordination compounds of cobalt(II) with carboxylate non–steroidal anti–inflammatory drugs: Structure and biological profile

Dimolybdenum (II,II) paddlewheel complexes bearing non-steroidal anti-inflammatory drug ligands: Insights into the chemico-physical profile and first biological assessment

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

Synthesis, Characterization, and Biological Activities of a Cu(II) Complex with the Non-Steroidal Antiinflammatory Drug Flufenamic Acid

Synthesis, structural characterization and evaluation of anticancer activity of polymeric silver(I) complexes based on niflumic acid/naproxen and picoline derivatives